简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-09-29 09:27 Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
2022-09-28 15:29 Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse
2022-09-28 10:30 Biocytogen to Present at BioJapan2022, Introducing Innovative R&D Platforms, Bispecific ADC Programs and Pipeline Progress
2022-09-27 14:19 New Survey from Philip Morris International Reveals Strong Societal Support for Disruptive Innovations to Drive Public Health Progress
2022-09-27 09:25 Covetrus Names Michelle Bonfilio as Chief People Officer
2022-09-26 09:52 Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660
2022-09-26 09:37 Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License Agreement with Merck
2022-09-23 16:25 Arthur D. Little Launches Blue Shift Reports, Addresses Business Potential of Quantum Computing
2022-09-22 08:52 Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor
2022-09-21 16:12 Blood Cancer Discovery Publication Further Validates Exscientia's AI Precision Medicine Platform for Improving Patient Outcomes
2022-09-21 10:10 Prolific Machines Raises $42M From Top Planetary Health Investors to Build the Assembly Line for Biology
2022-09-20 18:19 The Carbon Trust Validates Greenhouse Gas Effects of Phibro Feed Additive
2022-09-20 16:07 Galderma Debuts The Sensitive Skincare Faculty, a Global Expert Group to Improve Understanding and Management of Sensitive Skin
2022-09-20 08:52 Takeda Signs Virtual Power Purchase Agreement with Enel North America to Advance Renewable Energy Production in the United States
2022-09-19 18:45 Hyperice Brings the Heat With Introduction of All-New Venom Go and Venom 2
2022-09-19 14:08 LEO Pharma Receives Positive CHMP Opinion of Adtralza® (tralokinumab) for the Treatment of Adolescents With Moderate-to-Severe Atopic Dermatitis
2022-09-19 09:36 Takeda Receives Positive CHMP Opinion for Maribavir for the Treatment of Adults with Post-transplant Cytomegalovirus (CMV) Refractory (With or Without Resistance) to Prior Therapies
2022-09-16 15:25 UAE’s Burjeel Medical City Successfully Carries Out Its First Kidney Transplant
2022-09-16 15:14 DentalMonitoring Launches DM Insights
2022-09-16 15:10 Takeda Selects New Partners for Global Corporate Social Responsibility (CSR) Program to Strengthen Health Systems in Low- and Middle-Income Countries

Business Wire Weibo

Press Releases

Latest Releases